Correction to: Modern Pathology
There are some errors in the P values reported in this paper. The correct results and table are shown below:
DCIS regression according to clinicopathological characteristics
We identified signs of DCIS regression in 30 out of 450 (6.7%) patients. The association between DCIS regression and DCIS characteristics is reported in Table 2. Overall, DCIS regression was associated with a larger size (P = 0.001), high grade (P < 0.0001), presence of comedonecrosis (P = 0.013), ER-PR-HER2+ IHC subtype (P < 0.0001) and TIL-high DCIS (P = 0.006). After multivariate analysis, only the association between DCIS regression and ER-PR-HER2+ IHC subtype remained significant (P = 0.001).
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41379-020-0553-9.
Rights and permissions
About this article
Cite this article
Agahozo, M.C., Westenend, P.J., van Bockstal, M.R. et al. Correction: Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent. Mod Pathol 34, 1039–1040 (2021). https://doi.org/10.1038/s41379-020-00707-4
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41379-020-00707-4
This article is cited by
-
Analysis of prognostic factors after pulmonary resection for metastatic breast cancer: a 23-year single-institution retrospective study
General Thoracic and Cardiovascular Surgery (2025)
-
Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast
Journal of Mammary Gland Biology and Neoplasia (2021)
-
Changes in Immune Cell Types with Age in Breast are Consistent with a Decline in Immune Surveillance and Increased Immunosuppression
Journal of Mammary Gland Biology and Neoplasia (2021)
